Login / Signup

Getting the clock back on its feet: targeting the circadian clock to treat osteoarthritis.

Thomas Mortimer
Published in: The FEBS journal (2022)
Growing evidence suggests that circadian clock dysfunction may contribute to the pathology of osteoarthritis. In this issue, He et al. use in vivo and human-derived osteoarthritis models to demonstrate the therapeutic potential of pharmacologically manipulating components of the cartilage circadian clock. In doing so, the authors provide an important proof-of-principle supporting circadian clock-targeted therapy as a treatment option for osteoarthritis. Comment on: https://doi.org/10.1111/febs.16601.
Keyphrases
  • rheumatoid arthritis
  • knee osteoarthritis
  • endothelial cells
  • cancer therapy
  • induced pluripotent stem cells
  • combination therapy
  • drug delivery
  • replacement therapy